MEMRIL

Description

Composition: Memantine Hydrochloride

Product Type: Tablet

Quantity: 30 tablets

Strength/Dosage: 10 mg per tablet

Indications:

Treatment of moderate to severe Alzheimer’s disease.
Management of cognitive symptoms such as memory loss, confusion, and difficulty concentrating.
Improvement of functional ability in patients with Alzheimer’s disease.
Adjunctive therapy in combination with acetylcholinesterase inhibitors for enhanced symptom control.
Reduction of behavioral symptoms associated with dementia, such as agitation and aggression.